OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells is a paramount challenge for the biopharmaceutical industry. A variety of strategies are employed to antibody titer, including process parameter optimization, genetic engineering, and implementation of perfusion technologies. Fine-tuning growth parameters